Sepsis Trieste – II° ed. 2024

The “Sepsis Trieste” congress, scheduled for 20–21 September 2024, will offer a comprehensive overview of current approaches to the diagnosis and management of sepsis, with contributions from prominent international specialists. The programme will address key clinical challenges, ranging from early microbiological assessment to antibiotic strategies and the treatment of organ dysfunction. Researchers from the HERVCOV consortium will contribute to the scientific sessions with two interventions: Professor Claudia Matteucci will present the contribution “Human endogenous retroviruses in sepsis” on 20 September within the panel dedicated to emerging pathogens and antimicrobial treatments, and the consortium team (Tor Vergata University) will also deliver the study “The potential contribution of flow cytometry to characterize and define extracellular vesicles: the experience in COVID-19 and post-acute sequelae of SARS-CoV-2 infection” presented by the group of authors involved in this research.

Click here for the programme.